Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury

Author(s):
Wagenaar, G.T.M.; Laghmani, E.; Fidder, M.; Sengers, R.M.A.; Visser, Y.P. de; Vries, L. de; Rink, R.; Roks, A.J.M.; Folkerts, G.; Walther, F.J.
Published
2013
Publication type
Article / Letter to editor
bronchopulmonary dysplasiaangiotensin-(1-7)lung inflammationright ventricular hypertrophypulmonary hypertension
Date issued
2013-09-30
Language
English
Is part of
AJP - Lung Cellular and Molecular Physiology (2013), Vol. 305, no. 5, p. L341-L351
hdl
1887/101140
doi
10.1152/ajplung.00360.2012